Based on the clinical annotations in this study, we observed, for the first time to our knowledge, that CD73 expression is increased in IDH1 mutant gliomas, and, mechanistically, we showed that it is induced by the oncometabolite (R)-2-hydroxyglutarate (2-HG). The gene discussed is IDH1; the disease is central nervous system cancer.